APM: Metabolic Monitoring for Children and Adolescents on Antipsychotics
Percentage with both glucose/HbA1c AND lipid testing during measurement year.
Measure description
Percentage with both glucose/HbA1c AND lipid testing during measurement year.
Eligible population
Pediatric members on second-generation antipsychotic
Performance drivers
Metabolic side effects of antipsychotics in pediatrics under-monitored.
Documentation & PA strategy
Document baseline + annual fasting glucose/HbA1c + lipid panel. Pediatric SGA PA may require monitoring proof at renewal.
Why HEDIS matters for prior authorization
Health plans align prior authorization criteria with HEDIS measures: documenting your patient meets the HEDIS definition often streamlines or eliminates PA hurdles. For Medicare Advantage in particular, plans are heavily incentivized via Star Ratings to push members and providers toward measure compliance, which translates into faster approvals for measure-aligned services.
Frequently asked questions
What does HEDIS measure APM measure?
Percentage with both glucose/HbA1c AND lipid testing during measurement year.
What drives performance on this measure?
Metabolic side effects of antipsychotics in pediatrics under-monitored.
How should clinicians document for this measure?
Document baseline + annual fasting glucose/HbA1c + lipid panel. Pediatric SGA PA may require monitoring proof at renewal.
What is the eligible population?
Pediatric members on second-generation antipsychotic
Streamline APM workflow with ApprovalHelp
ApprovalHelp automates clinical PA, appeals, and HEDIS-aligned documentation. no setup fee.
Get started →Contact: hello@approvalhelp.com